Recent news on Ondansetron

Dr Reddy`s: Going strong  -  May 22, 2007
Business Standard,Dr Reddy’s Laboratories reported an impressive performance in the March 2007 quarter, spurred by its 180-day exclusivity for ondansetron hydrochloride

Dr Reddy's gets a shot in the arm  -  May 22, 2007
Economic Times,This was offset to some extent by some high margin product launches such as fexofenadine and ondansetron. Compared to increase in sales, a lower increase in

International market boosts Dr Reddy's revenue  -  May 23, 2007
In-PharmaTechnologist.com,In December last year, the company began selling ondansetron, its generic version of GlaxoSmithKline's anti-nausea drug Zofran. It has 180 days to sell the

DRL records $216 million profit  -  May 18, 2007
The Asian Age,The company had also obtained a second 180-day marketing exclusivity for a generic drug in the US market with the launch of ondansetron hydrochloride

Preclinical Development and Clinical Implementation of Treatments ...  -  May 18, 2007
Focus (subscription)Other receptor modulators showing some positive data include topiramate (58) and ondansetron (59), although these have not yet been approved by the FDA.

Odansetron Versus Metoclopramide for Nausea and Vomiting in the ...  -  Apr 27, 2007
AEM (subscription)The objective is to compare the efficacy of usual (4 mg) and low (2 mg) dose ondansetron and 10 mg metoclopramide in relief of nausea and vomiting in ED

GSK hit by strong sterling but underlying growth is good  -  Apr 26, 2007
Pharma Times (subscription),The antidepressant Wellbutrin XL, a sustained-release form of bupropion, fell 37% to £109 million, while Zofran (ondansetron), its nausea treatment for

GSK hit by strong sterling but underlying growth is good  -  26 Apr 2007
Pharma Times (subscription),The antidepressant Wellbutrin XL, a sustained-release form of bupropion, fell 37% to £109 million, while Zofran (ondansetron), its nausea treatment for

Out of the Gate: MGI Pharma Down  -  Apr 19, 2007
Forbes,2007 revenue step-down for Aloxi, seemingly confirming our fear that oncologists may not be done switching to generic ondansetron," he said.

MGI PHARMA Reports First Quarter 2007 Financial Results  -  Apr 19, 2007
PharmaLive.com (press release),...nausea and vomiting market following the introduction of multiple generic ondansetron products at the end of the fourth quarter of 2006.

MGI Pharma Swings to Profit in 1Q  -  Apr 18, 2007
Forbes,Sales of MGI's drug Aloxi, which treats chemotheraphy-induced nausea, dropped 25 percent to $47.3 million, due to the introduction of generic ondansetron

Skye formulation accepted for GSK drug  -  Apr 16, 2007
In-PharmaTechnologist.com,...these gains are likely to be offset by declines in Zofran (ondansetron), Flonase (fluticasone) and Wellbutrin (bupropion) due to generic competition.

Windfall for cos eyeing US oncology market  -  Apr 10, 2007
Economic Times,Zofran, also known under its generic name Ondansetron, recorded sales of over $500 million last year in the US. Gemcitabine, marketed by US drug giant Eli

See moderate to good quarter for pharma: Nimish Mehta  -  Apr 9, 2007
Moneycontrol.com,...and there would be an unusual one-time growth that may come in for Dr Reddy as they launch the 180-day exclusivity product Zofran on Ondansetron.

Hana Biosciences Reports Likely Delay in Launch of Zensana  -  Feb 21, 2007
PharmaLive.com (press release),Ondansetron, a selective blocking agent of the hormone serotonin, is an FDA-approved active ingredient that is widely used in tablet form to prevent

NovaDel Comments on Delay in Zensana Launch, as Announced by Hana ...  -  Feb 21, 2007
PharmaLive.com (press release),Zensana(TM) is an oral spray formulation of ondansetron that is indicated for the prevention of chemotherapy- and radiation-induced and post-operative

SCOLR Pharma Announces Positive Results from Its Second 24 Hour ...  -  Feb 6, 2007
Business Wire (press release),Stephen Turner, SCOLR Pharma's Vice President and Chief Technology Officer, said, "The data from this second ondansetron study provides additional evidence

Topline will cross USD 500 mn next fiscal: Wockhardt  -  Feb 23, 2007
Moneycontrol.com,Wockhardt USA Inc now markets 15 products, including Ondansetron launched on the first day after patent expiry.

Hana drug approval likely to be delayed  -  Feb 20, 2007
San Francisco Business Times,...is committed to development and eventual sale of the drug. Zensana is a formulation of ondansetron, an antiemetic drug already in use in tablet form.

SCOLR Pharma (DDD) Announces Positive Results from Its Second 24 ...  -  Feb 6, 2007
StreetInsider.com (subscription),The results from our ondansetron study further demonstrate the applicability of our CDT technology to a growing number of challenging compounds and support

Market Report -- In Play (DDD)  -  Feb 6, 2007
MSN MoneyScolr Pharma announces "positive" results from Its second 24 hour CDT-Ondansetron trial; ends development of extended release phenylephrine Co announces

India's Cipla, Glenmark get tentative FDA nods  -  Feb 8, 2007
ReutersBO: Quote, Profile, Research) has received tentative approval for ondansetron hydrochloride tablets, which is used in controlling nausea and vomiting caused

Research and Markets: Par Pharmaceutical Generics Company ...  -  Feb 2, 2007
Business Wire (press release),The most recent drug to be approved is ondansetron, a version of Merck’s Zofran. The company boosted its position in the US market in 2006,

Hana Shares Plunge on Zensana Delay News  -  Feb 21, 2007
Forbes,..."We assume a bear case in which Zensana delays are lengthy and other increasingly competitive generic ondansetron equivalents enter the market establishing

Premarket Movers: Jupitermedia Rockets  -  Feb 21, 2007
Forbes,..."We assume a bear case in which Zensana delays are lengthy and other increasingly competitive generic Ondansetron equivalents enter the market establishing

AMDL to Present, Discuss Successes in China, at Roth Capital ...  -  Feb 21, 2007
PR Newswire (press release),The Company also recently announced the introduction in China of Ondansetron Hydrochloride, which is prescribed for nausea caused by chemotherapy,

Pediatric studies lead to more information on drug labels  -  Feb 1, 2007
AAP News (subscription)Zofran (ondansetron) Injection studies established dosing for the prevention of chemotherapy-induced nausea and vomiting for children 6 to 48 months old.

Novadel Pharma: Poised for Growth  -  Feb 14, 2007
Seeking Alpha,Zensana is Novadel’s formulation of ondansetron, the most widely prescribed anti-emetic (anti-nausea) compound used following chemotherapy.

Cipla and Glenmark get tentative nods from USFDA  -  Feb 9, 2007
Myiris.com,Meanwhile, drug maker Glenmark Pharmaceuticals has also received tentative approval for ondansetron hydrochloride tablets, which is used in controlling

Correction: MGI Pharma Earnings Story  -  Feb 8, 2007
Forbes,...due to a reduction in specialty distributor inventory as a generic version of ondansetron, a similar drug, was introduced and selling prices declined.

MGI PHARMA Reports Fourth Quarter and Full Year 2006 Financial Results  -  Feb 8, 2007
PharmaLive.com (press release),...which coincided with the anticipated introductions of generic ondansetron both in November and at the end of the fourth quarter, and a decline in net

AMDL to Present at RedChip Investment Conference; China Products ...  -  Feb 8, 2007
Yahoo! News (press release)Mr. Dreher will tell the potential investors about recent successes for the Company in China, including the introduction of Ondansetron Hydrochloride,

ScinoPharm Launches More Cancer Treatment APIs in the US  -  18 Jan 2007
ClickPress (press release),Oncological API specialist ScinoPharm announced the launch of Ondansetron Hydrochloride (HCl) API in the US following its successful introduction of another

Abraxis BioScience Launches Ondansetron Injection, USP  -  Jan 4, 2007
PharmaLive.com (press release),According to IMS, sales in 2005 of ondansetron in the United States exceeded $587 million. The company markets ondansetron in AP-rated single-dose and

FDA Approves First Generic Ondansetron Tablets, Orally ...  -  Jan 4, 2007
Medical News Today (press release),The Food and Drug Administration today approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating Tablets and Oral Solution

Wockhardt launches Ondansetron in US  -  Dec 27, 2006
Business Standard,Wockhardt’s US subsidiary, Wockhardt USA, has launched Ondansetron injection in the United States on December 26. Ondansetron is the generic version of

Hospira Launches Ondansetron Injection  -  Dec 27, 2006
PharmaLive.com (press release),Ondansetron is an antiemetic used for the prevention of nausea and vomiting caused by cancer chemotherapy and anesthesia/surgery.

Hospira Launches Ondansetron Injection  -  Dec 27, 2006
Drug Newswire (press release),Ondansetron is an antiemetic used for the prevention of nausea and vomiting caused by cancer chemotherapy and anesthesia/surgery. It is currently available

Par Pharmaceutical Receives Approval For Ondansetron Orally ...  -  Dec 29, 2006
Medical News Today (press release),Ondansetron ODT is the generic version of GlaxoSmithKline's Zofran ODT(R). The product is used for the prevention of nausea and vomiting associated with

Hospira Launches Ondansetron Injection  -  Dec 26, 2006
Earthtimes.org26 -- Hospira, Inc. , a leading global hospital products company, today announced the launch of ondansetron injection. The medication is the generic version

Wockhardt launches Ondansetron Injection in the US, on Day 1  -  Dec 27, 2006
Equity Bulls,Wockhardt Ltd has announced that Wockhardt's USA Inc. Wockhardt's US subsidiary, launched Ondansetron injection in the United States on December 26, 2006,

Bedford Laboratories(TM) to Begin Shipping Ondansetron Injection USP  -  Dec 27, 2006
Drug Newswire (press release),Ondansetron Injection USP is indicated for prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy,

Wockhardt launches Ondansetron injection in US,on Day 1  -  Dec 27, 2006
Moneycontrol.com,Wockhardt USA Inc., Wockhardt's US subsidiary, launched Ondansetron injection in the United States on Tuesday, the first working day after the patent for

Wockhardt launches Ondansetron injection in the US  -  Dec 27, 2006
Myiris.com,Ondansetron is the generic version of Glaxo SmithKline`s Zofran injection and is used in controlling nausea and vomiting following cancer chemotherapy.

Dr. Reddy's Announces Final Approval of Ondansetron Tablets with ...  -  Dec 27, 2006
India PRwire (Press Release),Dr. Reddy’s Ondansetron Hydrochloride Tablets are the AB-rated generic equivalent of GSK’s Zofran® Tablets, a product indicated for the prevention of nausea

Barr's Subsidiary PLIVA Launches Ondansetron 4 mg and 8 mg Orally ...  -  Dec 27, 2006
Drug Newswire (press release),Under the terms of the agreement, PLIVA, Inc. has exclusive rights to market, sell and distribute Ondansetron 4 mg and 8 mg Orally Disintegrating Tablets in

DRL gets US nod for multiple dosages of Ondansetron  -  Dec 27, 2006
Economic Times,MUMBAI: Pharmaceutical firm Dr Reddy's Laboratories Ltd has received approval from the US Food and Drug Administration to market Ondansetron Hydrochloride

Par Pharmaceutical Receives Approval for Ondansetron Orally ...  -  Dec 26, 2006
PR Newswire (press release),Par to Manufacture, Barr Pharmaceuticals Inc.'s PLIVA Subsidiary to Market Product; Ondansetron ODT Awarded 180 Days' Marketing Exclusivity WOODCLIFF LAKE,

Wockhardt launches Ondansetron injection in US  -  Dec 27, 2006
India Infoline.com,Wockhardt Ltd. said on Wednesday that its US subsidiary launched Ondansetron injection on Tuesday, the first working day after the patent for the product

Dr. Reddy's gets US FDA OK for ondansetron tablets  -  Dec 26, 2006
ReutersBO: Quote, Profile , Research) said on Wednesday it had received final approval from the US Food and Drug Administration for ondansetron hydrochloride

Dr Reddy's gets USFDA nod for Ondansetron  -  Dec 27, 2006
Moneycontrol.com,Dr Reddy's Laboratories Ltd today got the final approval for Ondansetron Hydrochloride, the generic equivalent of the blockbuster drug `Zofran',

Dr Reddy's announces final approval of Ondansetron tablets with ...  -  Dec 27, 2006
Equity Bulls,The Company's Ondansetron Hydrochloride Tablets are the AB-rated generic equivalent of GSKs Zofran® Tablets, a product indicated for the prevention of

FDA Approves First Generic Ondansetron Tablets, Orally ...  -  Dec 27, 2006
PharmaLive.com (press release),27, 2006-The Food and Drug Administration today approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating Tablets and Oral

Bedford Laboratories(TM) to Begin Shipping Ondansetron Injection USP  -  Dec 26, 2006
Earthtimes.org26 -- Bedford Laboratories(TM), a division of Ben Venue Laboratories Inc., announced that it will begin marketing Ondansetron Injection USP as of December

Par Pharmaceutical (PRX) Receives Final FDA Approval for ...  -  Dec 26, 2006
StreetInsider.com (subscription),Ondansetron ODT is the generic version of GlaxoSmithKline's (NYSE: GSK) Zofran ODT. The product is used for the prevention of nausea and vomiting associated

Par Pharmaceutical Receives Approval for Ondansetron Orally ...  -  Dec 26, 2006
Yahoo! News (press release)Ondansetron ODT is the generic version of GlaxoSmithKline's Zofran ODT®. The product is used for the prevention of nausea and vomiting associated with

Dr. Reddy's Laboratories (RDY) Receives Final FDA Approval for ...  -  Dec 27, 2006
StreetInsider.com (subscription),Dr. Reddy's Ondansetron Hydrochloride Tablets are the AB-rated generic equivalent of GSK's (NYSE: GSK) Zofran Tablets, a product indicated for the

Dr. Reddy's Announces Final Approval of Ondansetron Tablets with ...  -  Dec 27, 2006
PharmaLive.com (press release),Dr. Reddy's Ondansetron Hydrochloride Tablets are the AB-rated generic equivalent of GSK's Zofran(R) Tablets, a product indicated for the prevention of

Dr Reddy`s gets approval for Ondansetron tablets  -  Dec 27, 2006
Myiris.com,Dr Reddy`s Laboratories has received approval from US Food and Drug Administration for the company`s Abbreviated New Drug Application (ANDA) for Ondansetron

DRL bags drug rights in US  -  Dec 27, 2006
Calcutta Telegraph,27: Dr Reddy’s Laboratories (DRL) has bagged a 180-day marketing exclusivity for Ondansetron Hydrochloride tablets in the US.

Dr Reddy's gets USFDA nod for anti-nausea drug  -  Dec 27, 2006
Economic Times,With the approval, Dr Reddy's can exclusively market ondansetron tablets for 180-day period. The company will commence the shipment of this product shortly.

Business Standard Columnists  -  Dec 27, 2006
Business Standard,Two Indian generic players have received the US FDA approvals and will be launching the generic version of Glaxo’s Zofran (generic drug ondansetron),

Wockahrdt introduces oncological product in the US  -  Dec 27, 2006
domain-B,Wockhardt's US subsidiary Wockhardt's USA Inc, has introduced Ondansetron injection in the US on December 26, 2006, the first working day after the patent

Active stock: Dr Reddy`s advances on receiving US FDA approval for ...  -  Dec 27, 2006
Myiris.com,The shares of Dr. Reddy`s (Q, N,C,F)* Laboratories are trading higher by 1.66% at BSE (1.45 pm) on receiving approval from US FDA for Ondansetron

Market Report -- In Play (PRX)  -  Dec 26, 2006
MSN MoneyPar Pharmaceutical receives approval for Ondansetron orally disintegrating tablets Co announces it has received final approval from the FDA for its

Gastrointestinal Medications  -  Jan 5, 2007
Psychosomatics (subscription)The most prominent of the 5HT 3 RAs are ondansetron, dolasetron, granisetron, palonosetron, and tropisetron. Ondansetron and granisetron are the earliest

DRL's generic version of Zofran likely to generate Rs 200 cr in 6 ...  -  Dec 27, 2006
Economic Times,The US Food and Drug Administration (FDA) granted final approval for DRL’s abbreviated new drug application (ANDA) for four dosages of ondansetron

Dr Reddy's get USFDA approval  -  Dec 28, 2006
Andhra Cafe,...of Ondansetron Hydrochloride Tablets, 4mg, 8mg, 16mg and 24mg. Ondansetron Hydrochloride Tablets are the AB-rated generic equivalent of GSK's Zofran®

Business briefs  -  Dec 27, 2006
Chicago Sun-Times,Hospira Inc. announced the launch of ondansetron injection Tuesday. The medication is the generic version of GlaxoSmithKline's Zofran, which posted 2005 US

Dr Reddy's gets USFDA nod for anti-nausea drug  -  Dec 27, 2006
Business Standard,Ondansetron Hydrochloride Tablets are the AB-rated generic equivalent of GSK's Zofran® tablets, a product indicated for the prevention of nausea and

Dr Reddy's receives FDA approval for generic Zofran  -  Dec 28, 2006
newratings.comThe Indian company said it had received approval from the FDA to market ondansetron hydrochloride tablets, which are marketed by GlaxoSmithKline Plc (GSK)

Karvy rated Dr. Reddy`s Labs as `Market Performer` (CMP: Rs 808 ...  -  Dec 27, 2006
Myiris.com,Dr. Reddy`s has received the USFDA approval for Ondansetron HCL tablets 4mg, 8mg, 16mg and 24 mg dosage forms. The company has received the 180-day

Hospira launches generic Zofran  -  Dec 26, 2006
BusinessWeekOndansetron posted sales of about $300 million in the 12-month period ending in September, according to pharmaceutical data company IMS Health.

Hospira announces launch of generic version of Zofran  -  Dec 26, 2006
ReutersN: Quote, Profile , Research) on Tuesday announced its launch of ondansetron injection, a medication which is the generic version of GlaxoSmithKline Plc's

Par Gets OK for Generic Brand of Zofran  -  Dec 26, 2006
Houston Chronicle,Inc. on Tuesday said it received final approval from regulators for a generic version of Zofran ODT (ondansetron), which is used to prevent the nausea and

Dr Reddy’s strategy is Laxman, not Dhoni  -  Dec 27, 2006
Daily News & Analysis,Dr Reddy’s has won 180-day marketing exclusivity for Ondansetron, the generic version of Zofran, in four different strengths. That’sa sixer by any yardstick

Zofran to help build US business: Dr Reddy's  -  Dec 27, 2006
Moneycontrol.com,VC & CEO of Dr Reddy's Laboratories, GV Prasad comments on getting the exclusivity for Ondansetron soon after the rights for Simvastatin and Proscar got

Sección internacional  -  Dec 26, 2006
Bolsamania.com,...(PRN) - Bedford Laboratories(TM) to Begin Shipping Ondansetron Injection USP ... [+]. (PRN) - Dune Energy Announces Purchase of Additional Bayou Couba

Barr's Subsidiary PLIVA Launches Ondansetron 4 mg and 8 mg Orally ...  -  26 Dec 2006
PR Newswire (press release),Under the terms of the agreement, PLIVA, Inc. has exclusive rights to market, sell and distribute Ondansetron 4 mg and 8 mg Orally Disintegrating Tablets in

TradingMarkets 7 Stocks You Need to Know for Wednesday  -  26 Dec 2006
Trading Markets,Par Pharmaceutical (PRX | charts | news | PowerRating) announced that the FDA approved its new drug, Ondansetron ODT, which is a generic drug used to battle

(PRN) - World's Tallest Roses Reign at 2007 Rose Parade ... [+]  -  26 Dec 2006
Bolsamania.com,...(PRN) - Bedford Laboratories(TM) to Begin Shipping Ondansetron Injection USP ... [+]. (PRN) - Dune Energy Announces Purchase of Additional Bayou Couba

Generic Ondansetron injection approved  -  Nov 27, 2006
StTammany.com,The US Food and Drug Administration has approved the first generic versions of Zofran (ondansetron) injection and injection premixed.

FDA CAPSULES  -  Dec 5, 2006
Newsday,FDA APPROVES FIRST GENERIC ONDANSETRON INJECTION. The US Food and Drug Administration has approved first generic versions of Zofran (Ondansetron) Injection

NovaDel Pharma (NVD) Announces $14 Million in Financing From ...  -  Dec 15, 2006
StreetInsider.com (subscription),We are very excited about our development pipeline which includes ondansetron Oral Spray that is currently under late stage FDA review through our partner

Buy Dr Reddy's Labs with a target of Rs 800: Motilal Oswal  -  Dec 1, 2006
Moneycontrol.com,..."Confident of Zofran exclusivity - Management recently confirmed DRRD’s eligibility of Ondansetron 180-day exclusivity but launch is contingent on US FDA

FDA Approves Generic Version of Chemotherapy Drug  -  Nov 28, 2006
AXcess News,Ondansetron Injection packaged in single and multi-dose vials are manufactured by Teva Pharmaceuticals USA in North Wales, PA.

JP Morgan overweight on Dr Reddys Labs  -  Nov 27, 2006
Moneycontrol.com,Our model now reflects ondansetron exclusivity revenues of $26m in FY07E and FY08E each and sumatriptan revenues of USD 35 million in FY09E and potential

Dr Reddy crosses USD 1 billion in revenues  -  Dec 12, 2006
Moneycontrol.com,In the next two weeks, the US FDA approval for Zofran or anti-emetic drug Ondansetron, may provide the next revenue trigger for Dr Reddy's.

RESEARCH CALLS: Balaji Telefilms  -  Dec 4, 2006
Business Standard,The company is eligible of Ondansetron 180-day exclusivity but the launch is contingent on US FDA approval. Motilal expects one-time upside of $45 million

Research and Markets: Cipla Manufactures Apis And Formulation ...  -  Nov 27, 2006
PharmaLive.com (press release),Other firsts have included propranolol, ondansetron, salmeterol, montelukast, fluticasone propionate and doxazosin. In 2006, the company announced it was

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional